YH25448, a 3rd generation EGFR-TKI, in patients with EGFR-TKI-resistant NSCLC: Phase I/II study results
July 22, 2026
YH25448, a 3rd generation EGFR-TKI, in patients with EGFR-TKI-resistant NSCLC: Phase I/II study results
By: Oscotec 포토옹
COMPANY
SCIENCE
INVESTORS
Sustainability
CONTACT